SCOPUS 정보 검색 플랫폼

Volumn 46, Issue 3, 2002, Pages 828-833

Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans

(6) Bekersky, Ihor a Fielding, Robert M a Dressler, Dawna E a Lee, Jean W a Buell, Donald N a Walsh, Thomas J a

a ASTELLAS PHARMA GLOBAL DEVELOPMENT (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; LIPOSOME;

ADULT; ARTICLE; BACKACHE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FECES LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MALE; NAUSEA; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TANDEM MASS SPECTROMETRY;

ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYCHOLIC ACID; DRUG COMBINATIONS; FECES; FEMALE; HUMANS; LIPOSOMES; MALE; MASS SPECTROMETRY; MIDDLE AGED;

EID: 0036167883 PISSN: 00664804 EISSN: None Source Type: Journal
DOI: 10.1128/AAC.46.3.828-833.2002 Document Type: Article

Times cited : (271)

References (35)

1
- 0001240547
- AmBisome: Long circulating liposomal formulation of amphotericin B
- M. C. Woodle and G. Storm (ed.). Landes Bioscience, Georgetown, Tex.
- (1998) Long-circulating liposomes: Old drugs, new therapeutics , pp. 185-206
- Adler-Moore, J.¹ Proffitt, R.T.²

2
- 0029738917
- A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphotericin B formulation
- (1996) Ther. Drug Monit. , vol.18 , pp. 604-609
- Alak, A.¹ Moy, S.² Bekersky, I.³

3
- 0017805599
- Amphotericin B pharmacokinetics in humans
- (1978) Antimicrob. Agents Chemother. , vol.13 , pp. 271-276
- Atkinson, A.J.¹ Bennett, J.E.²

4
- 0029965353
- Pharmacokinetics of conventional formulation versus fat emulsion formulation of amphotericin B in a group of patients with neutropenia
- (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 609-612
- Ayestarán, A.¹ López, R.M.² Montoro, J.B.³ Estíbalez, A.⁴ Pou, L.⁵ Julià, A.⁶ López, A.⁷ Pascual, B.⁸

5
- 0033151650
- Lipid-based amphotericin B formulations: From animals to man
- (1999) Pharm. Sci. Technol. Today , vol.2 , pp. 230-236
- Bekersky, I.¹ Fielding, R.M.² Buell, D.³ Lawrence, I.⁴

6
- 0000219066
- New approaches to systemic antifungal therapy: Case studies of AmBisome and FK463
- (1999) Recent Res. Dev. Antimicrob. Agents Chemother. , vol.3 , pp. 407-413
- Bekersky, I.¹ Buell, D.² Tomishima, M.³ Maki, K.⁴ Lawrence, I.⁵ Fielding, R.M.⁶

7
- 0032708527
- Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome) in beagle dogs
- (1999) Pharm. Res. , vol.16 , pp. 1694-1701
- Bekersky, I.¹ Boswell, G.W.² Hiles, R.³ Fielding, R.M.⁴ Buell, D.⁵ Walsh, T.J.⁶

8
- 0034861066
- 14C-cholesterol labeled AmBisome to healthy volunteers
- (2001) J. Clin. Pharmacol. , vol.41 , pp. 963-971
- Bekersky, I.¹ Fielding, R.M.² Dressler, D.E.³ Kline, S.⁴ Buell, D.N.⁵ Walsh, T.J.⁶

9
- 0034469250
- Safety, toxicokinetics, and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): A 91-day study in rats
- (2000) Pharm. Res. , vol.17 , pp. 1494-1502
- Bekersky, I.¹ Boswell, G.W.² Hiles, R.³ Fielding, R.M.⁴ Buell, D.N.⁵ Walsh, T.J.⁶

10
- 0016224225
- Flucytosine and amphotericin B: Hemodialysis effects on the plasma concentration and clearance
- (1974) Ann. Intern. Med. , vol.80 , pp. 613-617
- Block, E.R.¹ Bennett, J.E.² Livoti, L.G.³ Klein, W.J.⁴ MacGregor, R.R.⁵ Henderson, L.⁶

11
- 0031893392
- Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 263-268
- Boswell, G.W.¹ Bekersky, I.² Buell, D.³ Hiles, R.⁴ Walsh, T.J.⁵

12
- 0031904301
- AmBisome (liposomal amphotericin B): A comparative review
- (1998) J. Clin. Pharmacol. , vol.38 , pp. 583-592
- Boswell, G.W.¹ Buell, D.² Bekersky, I.³

13
- 0024580972
- Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate
- (1989) Antimicrob. Agents Chemother. , vol.33 , pp. 362-368
- Collette, N.¹ Van Der Auwera, P.² Lopez, A.P.³ Heymans, C.⁴ Meunier, F.⁵

14
- 0027275566
- Physiological parameters in laboratory animals and humans
- (1993) Pharm. Res. , vol.10 , pp. 1093-1095
- Davies, B.¹ Morris, T.²

15
- 0026595038
- Relationship of pharmacokinetics and tissue distribution to reduced toxicity of colloidal amphotericin B in dogs
- (1992) Antimicrob. Agents Chemother. , vol.36 , pp. 299-307
- Fielding, R.M.¹ Singer, A.W.² Wang, L.H.³ Babbar, S.⁴ Guo, L.S.S.⁵

16
- 0031726732
- Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome)
- (1998) Pharm. Res. , vol.15 , pp. 1775-1781
- Fielding, R.M.¹ Lewis, R.O.² Moon-McDermott, L.³

17
- 0000401721
- Clinical and preclinical studies with low-clearance liposomal amikacin (MiKasome)
- M. C. Woodle and G. Storm (ed.). Landes Bioscience, Georgetown, Tex.
- (1998) Long-circulating liposomes: Old drugs, new therapeutics , pp. 213-225
- Fielding, R.M.¹ Mukwaya, G.² Sandhaus, R.A.³

18
- 0034955645
- Relationship of pharmacokinetically calculated volumes of distribution to the physiologic distribution of liposomal drugs in tissues: Implications for the characterization of liposomal formulations
- (2001) Pharm. Res. , vol.18 , pp. 238-242
- Fielding, R.M.¹

19
- 0031605615
- Clinical pharmacology of systemic antifungal agents: A comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development
- (1998) Adv. Pharmacol. , vol.44 , pp. 343-500
- Groll, A.¹ Piscitell, S.² Walsh, T.J.³

20
- 0030950678
- Pharmacokinetics of liposomal amphotericin B (AmBisome) in critically ill patients
- (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 1275-1280
- Heinemann, V.¹ Bosse, D.² Jehn, U.³ Kähny, B.⁴ Wachholz, K.⁵ Debus, A.⁶ Scholz, P.⁷ Kolb, H.-J.⁸ Wilmanns, W.⁹

21
- 0033986938
- Comparison of the effects of liposomal amphotericin B and conventional amphotericin B on propafenone metabolism and hepatic cytochrome P-450 in rats
- (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 131-133
- Inselmann, G.¹ Volkmann, A.² Heidemann, H.T.³

22
- 0025816499
- Comparative safety, tolerance, and pharmacokinetics of amphotericin B lipid complex and amphotericin B desoxycholate in healthy male volunteers
- (1991) J. Infect. Dis. , vol.164 , pp. 418-421
- Kan, V.L.¹ Bennett, J.E.² Amantea, M.A.³ Smolskis, M.C.⁴ McManus, E.⁵ Grasela, D.M.⁶ Sherman, J.W.⁷

23
- 0021201964
- Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeys
- (1984) Antimicrob. Agents Chemother. , vol.26 , pp. 446-449
- Kim, H.¹ Loebenberg, D.² Marco, A.³ Symchowicz, S.⁴ Lin, C.⁵

24
- 0021233529
- Mechanisms of bile formation, hepatic uptake, and biliary excretion
- (1984) Pharmacol. Rev. , vol.36 , pp. 1-67
- Klaassen, C.D.¹ Watkins, J.B.²

25
- 0028266748
- Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits
- (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 713-718
- Lee, J.W.¹ Amantea, M.² Navarro, E.³ Francis, P.⁴ McManus, E.⁵ Schaufele, R.⁶ Bacher, J.⁷ Pizzo, P.A.⁸ Walsh, T.J.⁹

26
- 0035014441
- Quantitation of free and total amphotericin B in human biological matrices by a liquid chromatography tandem mass spectrometric method
- (2001) Ther. Drug Monit. , vol.23 , pp. 268-276
- Lee, J.W.¹ Petersen, M.E.² Lin, P.³ Dressler, D.⁴ Bekersky, I.⁵

27
- 0014707434
- Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion
- (1970) J. Pharm. Sci. , vol.59 , pp. 53-55
- Loo, J.C.K.¹ Riegelman, S.²

28
- 0021709937
- Altered tissue distribution of amphotericin B by liposomal encapsulation: Comparison of normal mice to mice infected with Candida albicans
- (1984) Cancer Drug Rev. , vol.1 , pp. 199-205
- Lopez-Berestein, G.¹ Rosenblum, M.G.² Mehta, R.³

29
- 0029872367
- Fate of liposomes in vivo: A brief introductory review
- (1996) J. Liposome Res. , vol.6 , pp. 3-17
- Papahadjopoulos, D.¹

30
- 0002921899
- Distribution
- Lea and Febiger, Philadelphia, Pa.
- (1994) Clinical pharmacokinetics: Concepts and applications, 3rd ed. , pp. 137-155
- Rowland, M.¹ Tozer, T.N.²

31
- 0035033898
- 14C] cholesterol-AmBisome following a single intravenous administration to rats
- (2001) Drug Metab. Dispos. , vol.29 , pp. 681-685
- Townsend, R.W.¹ Zutshi, A.² Bekersky, I.³

32
- 0031716174
- Safety, tolerance and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 2391-2398
- Walsh, T.J.¹ Yeldandi, V.² McEvoy, M.³ Gonzalez, C.⁴ Chanock, S.⁵ Freifeld, A.⁶ Seibel, N.I.⁷ Whitcomb, P.O.⁸ Jarosinski, P.⁹ Boswell, G.¹⁰ Bekersky, I.¹¹ Alak, A.¹² Buell, D.¹³ Barret, J.¹⁴ Wilson, W.¹⁵

33
- 0033545538
- Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
- (1999) N. Engl. J. Med. , vol.340 , pp. 764-771
- Walsh, T.J.¹ Finberg, R.W.² Arndt, C.³ Hiemenz, J.⁴ Schwartz, C.⁵ Bodensteiner, D.⁶ Pappas, P.⁷ Seibel, N.⁸ Greenberg, R.N.⁹ Dummer, S.¹⁰ Schuster, M.¹¹ Holcenberg, J.S.¹²

34
- 0026675504
- High-performance liquid chromatographic analysis of amphotericin B in plasma, blood, urine and tissues for pharmacokinetic and tissue distribution studies
- (1992) J. Chromatogr. , vol.579 , pp. 259-268
- Wang, L.H.¹ Smith, P.C.² Anderson, K.L.³ Fielding, R.M.⁴

35
- 0028306292
- Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: Role of lipid transfer protein
- (1994) J. Pharm. Sci. , vol.83 , pp. 1006-1010
- Wasan, K.M.¹ Morton, R.E.² Rosenblum, M.G.³ Lopez-Berestein, G.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.